Wealthedge Investment Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Wealthedge Investment Advisors's BTAL Position: Q2 2026 in Review
Wealthedge Investment Advisors reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 18% in Q2 2026, selling an estimated $54.7K and leaving 20,453 shares worth $228K. The position accounts for 0.08% of the portfolio, ranked #134.
Wealthedge Investment Advisors first reported a position in BTAL in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.23M in Q3 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Wealthedge Investment Advisors held 20,453 shares of AGF US Market Neutral Anti-Beta Fund worth $228K as of Q2 2026.
- Wealthedge Investment Advisors sold 4,500 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $54.7K.
- AGF US Market Neutral Anti-Beta Fund made up 0.08% of Wealthedge Investment Advisors's portfolio in Q2 2026, its #134 holding.
- Wealthedge Investment Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and has held it in 5 quarters since.
- Wealthedge Investment Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $8.23M in Q3 2025.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Wealthedge Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.